| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8316568 | Clinica Chimica Acta | 2011 | 6 Pages |
Abstract
p53-phage ELISA system has an edge over single p53-ELISA. S-p53 Abs level correlates with cancer patients' clinicalpathological parameters and can predict the chemoresponse of ÎÎÎ stage NSCLC patients during MCV-based NACT treatment.
Keywords
tumor, node and metastasisNACTTNMSTBMECoGMVCAJCCCeACarcino-embryonic antigenno responsestable diseaseprogressive diseasecomputed tomographyChemosensitivityWorld Health OrganizationNSCLCNon-small cell lung cancereastern cooperative oncology groupNeoadjuvant chemotherapyPhage display technologywild-typePartial responseObjective responsecomplete responseAmerican Joint Committee on CancerWHO
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
De-Hai Yu, Jin-Hui Li, Yi-Chun Wang, Jian-Guo Xu, Peng-Tao Pan, Li Wang,